Free Trial
OTCMKTS:BICX

Biocorrx Q4 2025 Earnings Results & Report

Biocorrx logo
$0.21 0.00 (0.00%)
As of 11/13/2026 10:26 AM Eastern

Biocorrx beat analyst earnings expectations but missed on revenue in its Q4 2025 results, released March 31, 2026. The company reported EPS of $0.05 versus the -$0.06 consensus estimate, while revenue of -$150 thousand fell short of the $220 thousand estimate by $370 thousand.

Earnings Announcement Details

Quarter
Q4 2025
Report Date
Time
During Market Hours

Biocorrx EPS Results

Actual EPS
$0.05
Consensus EPS
-$0.06
Beat/Miss
Beat by +$0.11
One Year Ago EPS
N/A
EPS Beat Rate
3 of last 4 quarters

Biocorrx Revenue Results

Actual Revenue
-$150 thousand
Expected Revenue
$220 thousand
Beat/Miss
Missed by -$370.00 thousand
YoY Revenue Growth
N/A

Upcoming Earnings

Biocorrx's next earnings date is estimated for Tuesday, November 17, 2026, based on past reporting schedules.

Conference Call Resources

Biocorrx Q4 2025 Earnings FAQ

Biocorrx (OTCMKTS:BICX) reported earnings of $0.05 per share for Q4 2025, beating the consensus estimate of -$0.06. The report was announced on Tuesday, March 31, 2026.

Biocorrx reported revenue of -$150 thousand for Q4 2025, against a consensus estimate of $220 thousand.

Biocorrx's next earnings date is estimated for Tuesday, November 17, 2026. MarketBeat tracks confirmed and estimated earnings dates for Biocorrx on the company's earnings history page.

Biocorrx Earnings Headlines

Biocorrx (BICX) Projected to Release Quarterly Earnings on Tuesday
BioCorRx Inc
I'm handing you this one free
Elon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds. He licenses it from one overlooked company. That supplier just got a major catalyst. Musk filed to launch 1,000,000 satellites, a move analyst Dylan believes could drive a 100X bigger bill for this chipmaker starting December 8th.tc pixel
BioCorRx Inc.
See More Biocorrx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biocorrx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biocorrx and other key companies, straight to your email.

About Biocorrx

Biocorrx (OTCMKTS:BICX), Inc. is a healthcare company focused on substance-use-disorder treatment and related products. Its BioCorRx Recovery Program is an outpatient approach that combines medication-assisted treatment with counseling and ongoing support for people seeking treatment for alcohol or opioid dependence.

The company has also pursued pharmaceutical products intended to support addiction treatment, including long-acting formulations. Its business includes developing treatment offerings and working to make them available through healthcare providers.

BioCorRx has also offered UnCraveRx, a medically supervised weight-management program. Its activities are centered on treatment and support services rather than traditional pharmaceutical manufacturing or general medical care.

View Biocorrx Profile